The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pruritus Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
The global Pruritus Therapeutics market size is expected to reach US$ 18060 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pruritus Therapeutics in various end use industries. The expanding demands from the External Use, Oral and Injection,, are propelling Pruritus Therapeutics market. Antihistamines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Corticosteroids segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pruritus Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pruritus Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pruritus Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pruritus Therapeutics covered in this report include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc.
The global Pruritus Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Global Pruritus Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pruritus Therapeutics market, Segment by Type:
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Global Pruritus Therapeutics market, by Application
External Use
Oral
Injection
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
The global Pruritus Therapeutics market size is expected to reach US$ 18060 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pruritus Therapeutics in various end use industries. The expanding demands from the External Use, Oral and Injection,, are propelling Pruritus Therapeutics market. Antihistamines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Corticosteroids segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pruritus Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pruritus Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pruritus Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pruritus Therapeutics covered in this report include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc.
The global Pruritus Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Global Pruritus Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pruritus Therapeutics market, Segment by Type:
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Global Pruritus Therapeutics market, by Application
External Use
Oral
Injection
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pruritus Therapeutics
1.1 Pruritus Therapeutics Market Overview
1.1.1 Pruritus Therapeutics Product Scope
1.1.2 Pruritus Therapeutics Market Status and Outlook
1.2 Global Pruritus Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pruritus Therapeutics Market Size by Region (2018-2029)
1.4 Global Pruritus Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Pruritus Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pruritus Therapeutics Market Size (2018-2029)
1.6.1 North America Pruritus Therapeutics Market Size (2018-2029)
1.6.2 Europe Pruritus Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Pruritus Therapeutics Market Size (2018-2029)
1.6.4 Latin America Pruritus Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Pruritus Therapeutics Market Size (2018-2029)
2 Pruritus Therapeutics Market by Type
2.1 Introduction
2.1.1 Antihistamines
2.1.2 Corticosteroids
2.1.3 Calcineurin Inhibitors
2.1.4 Others
2.2 Global Pruritus Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pruritus Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pruritus Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pruritus Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pruritus Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pruritus Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pruritus Therapeutics Revenue Breakdown by Type (2018-2029)
3 Pruritus Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 External Use
3.1.2 Oral
3.1.3 Injection
3.2 Global Pruritus Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pruritus Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pruritus Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pruritus Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pruritus Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pruritus Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pruritus Therapeutics Revenue Breakdown by Application (2018-2029)
4 Pruritus Therapeutics Competition Analysis by Players
4.1 Global Pruritus Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2022)
4.3 Date of Key Players Enter into Pruritus Therapeutics Market
4.4 Global Top Players Pruritus Therapeutics Headquarters and Area Served
4.5 Key Players Pruritus Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Pruritus Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 J&J
5.1.1 J&J Profile
5.1.2 J&J Main Business
5.1.3 J&J Pruritus Therapeutics Products, Services and Solutions
5.1.4 J&J Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 J&J Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Pruritus Therapeutics Products, Services and Solutions
5.2.4 Abbott Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Pruritus Therapeutics Products, Services and Solutions
5.3.4 Amgen Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 LEO Pharma Recent Developments
5.4 LEO Pharma
5.4.1 LEO Pharma Profile
5.4.2 LEO Pharma Main Business
5.4.3 LEO Pharma Pruritus Therapeutics Products, Services and Solutions
5.4.4 LEO Pharma Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 LEO Pharma Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Pruritus Therapeutics Products, Services and Solutions
5.5.4 Novartis Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Bayer
5.6.1 Bayer Profile
5.6.2 Bayer Main Business
5.6.3 Bayer Pruritus Therapeutics Products, Services and Solutions
5.6.4 Bayer Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Bayer Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Pruritus Therapeutics Products, Services and Solutions
5.7.4 Pfizer Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 UCB Pharma
5.8.1 UCB Pharma Profile
5.8.2 UCB Pharma Main Business
5.8.3 UCB Pharma Pruritus Therapeutics Products, Services and Solutions
5.8.4 UCB Pharma Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 UCB Pharma Recent Developments
5.9 GlaxoSmithKline
5.9.1 GlaxoSmithKline Profile
5.9.2 GlaxoSmithKline Main Business
5.9.3 GlaxoSmithKline Pruritus Therapeutics Products, Services and Solutions
5.9.4 GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 GlaxoSmithKline Recent Developments
5.10 Galderma
5.10.1 Galderma Profile
5.10.2 Galderma Main Business
5.10.3 Galderma Pruritus Therapeutics Products, Services and Solutions
5.10.4 Galderma Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Galderma Recent Developments
5.11 Huapont
5.11.1 Huapont Profile
5.11.2 Huapont Main Business
5.11.3 Huapont Pruritus Therapeutics Products, Services and Solutions
5.11.4 Huapont Pruritus Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Huapont Recent Developments
6 North America
6.1 North America Pruritus Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pruritus Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pruritus Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pruritus Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pruritus Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pruritus Therapeutics Market Dynamics
11.1 Pruritus Therapeutics Industry Trends
11.2 Pruritus Therapeutics Market Drivers
11.3 Pruritus Therapeutics Market Challenges
11.4 Pruritus Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
